Otsuka Pharmaceutical to Acquire Transcend Therapeutics
– Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend's portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD) – TOKYO and NEW YORK, March 27, 2026 /PRNewswire/ -- Otsuka Pharmaceutical Co., Ltd....
CP
cision pr newswire
via Pr Newswire
Updated 1h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
ASM International (OTCMKTS:ASMIY) Upgraded to “Strong-Buy” at Zacks Research
Next
Graham Platner's Tattoo Controversy Isn't Holding Him Back in Senate Race
Related Articles
HealthNewly minted police constable credits visually impaired dad for milestone
Unknown-4h ago-1 sources
HealthSAVAGE HOUSE Trailer Unleashes a Wild 18th Century Comedy with Richard E. Grant and Claire Foy
Geektyrant-13h ago-1 sources
HealthOrganon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
Businesswire-13h ago-1 sources